Otsuka (OTCMKTS:OTSKY) Shares Gap Down – Should You Sell?

Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKYGet Free Report) shares gapped down prior to trading on Wednesday . The stock had previously closed at $36.94, but opened at $35.43. Otsuka shares last traded at $35.7150, with a volume of 939 shares changing hands.

Otsuka Price Performance

The company has a debt-to-equity ratio of 0.05, a current ratio of 2.21 and a quick ratio of 1.65. The firm has a market cap of $38.09 billion, a price-to-earnings ratio of 14.24, a P/E/G ratio of 2.62 and a beta of 0.01. The business’s 50-day moving average price is $36.78 and its two-hundred day moving average price is $35.17.

Otsuka (OTCMKTS:OTSKYGet Free Report) last posted its quarterly earnings results on Friday, July 31st. The company reported $0.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.51 by $0.19. The firm had revenue of $4.41 billion for the quarter, compared to analysts’ expectations of $3.95 billion. Otsuka had a net margin of 15.50% and a return on equity of 12.86%. Otsuka has set its FY 2026 guidance at 2.119-2.119 EPS. On average, research analysts forecast that Otsuka Holdings Co., Ltd. – Unsponsored ADR will post 2.23 EPS for the current fiscal year.

Otsuka Company Profile

(Get Free Report)

Otsuka Holdings Co, Ltd. is a Japan-based healthcare and consumer products group whose businesses span pharmaceuticals, nutraceuticals and consumer health products, as well as related medical and chemical activities. The company operates primarily through subsidiaries including Otsuka Pharmaceutical Co, Ltd. and serves customers in Japan and international markets.

Otsuka’s pharmaceutical operations focus on prescription medicines in areas such as psychiatry, oncology, nephrology, cardiovascular disease and several other therapeutic fields.

Further Reading

Receive News & Ratings for Otsuka Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Otsuka and related companies with MarketBeat.com's FREE daily email newsletter.